All products produced by Paw-Treats are not suitable for human consumption and must be kept away from children. The sale or use of the products by persons under 21 (twenty-one) years of age is not permitted. This product should only be used in accordance with the descriptions on the product label. This product should not be used in pregnant or lactating animals. Before using the product, consult a competent person (veterinarian, doctor, pharmacist or other authorized person and expert), especially if your animal has medical issues and/or is taking medications. None of the statements primarily on cannabis, cannabinoids, CBD or on other substances, in particular of the genus Cannabis sativa L, were reviewed by the FDA or EFSA. This product is therefore not intended for the diagnosis, treatment, cure or prevention of any disease.

  • Facebook - Bílý kruh
  • Paw-Treats Instagram

PAW-TREATS GMBH

Beim Goldenen Löwen 9
4052 Basel
Switzerland

contact@paw-treats.com

+41 61 511 25 85

© BY PAW-TREATS GMBH 2019

Watch our interview with

Dr. Med. Vet. Michaela Riedlova.

Serious assuring functionality and safety requires independent testing.

The clinical approach

In order to reliably guarantee the functionality and safety of our CBD treats and CBD oils for animals, independent functional tests are required. Therefore, independent veterinarians together with the CULS test our products according to established methods, which are also commonly used to evaluate the functionality and safety of conventional medicines. We conduct independent product tests and even double-blind studies with owner dogs, in which we test various physiological parameters and document the behaviour of the study dogs in their domestic environment. But don't worry! No dogs are harmed, we do not work with laboratory animals and all owners voluntarily agreed to participate in our studies!

 

Each of our Paw-Treats products thus proves that combining superior functionality, safety, quality and sustainability is possible in a natural and ethical way, and that makes us proud. In an independent preliminary study our Agility+ treats helped five of the six study dogs with osteoarthritis to significantly increase their overall well-being and their activity. Furthermore, the results of the main clinical trial will soon be published in a scientific journal under the name of the CULS, the Czech University of Life Sciences.